— Know what they know.
Not Investment Advice
Also trades as: 0IJO.L (LSE) · $vol 0M · EX9.DE (XETRA) · $vol 0M

EXEL NASDAQ

Exelixis, Inc.
1W: +1.5% 1M: +12.0% 3M: +18.1% YTD: +50.0% 1Y: +68.8% 3Y: +209.6% 5Y: +203.9%
$65.35
+0.24 (+0.37%)
 
Weekly Expected Move ±2.7%
$61 $63 $65 $66 $68
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 70 · $16.4B mcap · 214M float · 1.16% daily turnover · Short 56% of daily vol
Credit Risk of going bust: lower than 92% of companies Debt: 1.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.05 (down 99.9%), Exelixis, Inc. would be worth roughly what it owes.
Total debt $165.9M against a stock market value of $16.43B.
Distance to default 15.71 (Merton model): prices to 2026-10-27, balance sheet 2026-07-03, debt counted $83.0M (short-term plus half of long-term), stock volatility 33.8%; Altman Z'' 7.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Cash Flow Trends

Operating Cash Flow
$884M +26.3% ▲
5Y CAGR: +33.4%
Capital Expenditures
$40M +39.7% ▲
5Y CAGR: +5.6%
Free Cash Flow
$844M +33.2% ▲
5Y CAGR: +36.4%
Dividends Paid
$0 +0.0% ▲
Buybacks
$948M -45.3% ▼
Net Change in Cash
$265M +681.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$231M$182M$208M$521M$783M
Depreciation & Amort.$14M$21M$26M$29M$29M
Stock-Based Comp.$120M$108M$106M$94M$113M
Change in Working Capital-$39M-$13M-$14M-$13M-$191M
Other Non-Cash Items$29M$125M$141M$129M$25M
Operating Cash Flow$401M$363M$333M$700M$884M
— Investing Activities —
Capital Expenditures-$54M-$28M-$40M-$28M$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases-$1.4B-$1.5B-$902M-$928M-$611M
Investment Sales$1.4B$1.1B$1.0B$877M$1.0B
Other Investing-$10M-$111M-$122M-$38M-$62M
Investing Cash Flow-$43M-$524M-$27M-$117M$350M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0-$550M-$652M-$948M
Dividends Paid$0$0$0$0$0
Other Financing-$15M$586K$4M$23M-$71M
Financing Cash Flow-$15M$586K-$546M-$629M-$970M
Net Change in Cash$343M-$161M-$240M-$46M$265M
Cash End of Period$664M$503M$263M$217M$482M
Free Cash Flow$337M$224M$170M$634M$844M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms